Valor Biotherapeutics LLC

About Valor Biotherapeutics LLC

Valor Biotherapeutics, a joint venture between ImmunGene, Inc. and Caliber Biotherapeutics, is focused on the clinical development and commercialization of the next generation of monoclonal antibody-based therapeutics to treat cancer. For more information, please visit: www.valorbio.com.
LEADERSHIP:
Founder and CEO: Sanjay Khare
PRODUCTS:
All Products